Finance
Beta
search_spark
Ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
4575
Research
4575:TYO
check_indeterminate_small
CanBas Co Ltd (Parent)
Â¥556.00
arrow_upward
+2.02%
(
+11.00
) 1D
Jun 12, 3:30:00 PM GMT+9 · JPY
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
Earnings
Financials
insights_auto
Generating top insights for 4575...
Open
Â¥555
High
Â¥565
Low
Â¥550
Mkt. cap
10.96B
Avg. vol.
166.64K
Volume
138.10K
52-wk high
Â¥1,558
52-wk low
Â¥506
EPS
-Â¥61
Shares outstanding
5.66M
No. of employees
14
Open
Â¥555
High
Â¥565
Low
Â¥550
Mkt. cap
10.96B
Avg. vol.
166.64K
Volume
138.10K
52-wk high
Â¥1,558
52-wk low
Â¥506
EPS
-Â¥61
Shares outstanding
5.66M
No. of employees
14
Related stocks
7776
CellSeed Inc
Â¥213.00
-0.93%
arrow_downward
4896
K Pharma Inc
Â¥638.00
0.00%
190A
Chordia Therapeutics Inc
Â¥97.00
0.00%
4598
Delta-Fly Pharma Inc
Â¥130.00
-2.26%
arrow_downward
News stories
From sources across the web
Yahoo Finance
·
30 minutes ago
SpaceX Stock Has Begun Trading on the Nasdaq at $150. Here's Why Investors Are Bidding Up the Share Price.
ChartMill
·
21 minutes ago
Looking for the most active stocks in the S&P500 index on Friday?
Al Jazeera
·
19 minutes ago
Musk becomes first trillionaire as SpaceX debuts on Nasdaq
Nasdaq
·
4 hours ago
SpaceX (SPCX): Rocket Company Launches Historic IPO
Show more
About CanBas Co Ltd (Parent)
CEO
Takumi Kawabe M.D., Ph.D
Employees
14
Founded
Jan 18, 2000
Headquarters
Numazu, Shizuoka, Japan
Sector
Biotechnology
Website
canbas.co.jp
Previous reports
All values in JPY
Loading Previous Earnings...
Income statement
Balance sheet
Cash flow
Income statement
Revenue
Net income
calendar_month
Quarterly
Quarterly
Annual
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
239.00M
283.00M
162.00M
241.00M
Cost of revenue
239.00M
283.00M
162.00M
241.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-23.00M
77.00M
78.00M
75.00M
Operating expense
72.00M
77.00M
78.00M
75.00M
Total operating expenses
311.00M
360.00M
240.00M
316.00M
Operating income
-311.00M
-360.00M
-240.00M
-316.00M
Other non operating income
-1.00M
1.00M
-
-
EBT including unusual items
-325.00M
-348.00M
-220.00M
-305.00M
EBT excluding unusual items
-325.00M
-348.00M
-220.00M
-305.00M
Income tax expense
1.00M
-
-
-
Effective tax rate
-0.31%
-
-
-
Other operating expenses
95.00M
-
-
-
Net income
-326.00M
-348.00M
-220.00M
-305.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
2.00M
-
2.00M
Interest expense
-
-
-
-
Net interest expenses
-
2.00M
-
2.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Ask anything
edit_square
New thread
notes_spark
Thread history
add
Add Tool
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
add
Add Tool
travel_explore
Deep Search
arrow_upward
Ask AI
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer